Lv1
30 积分 2023-01-30 加入
Targeting the future: Antibody-Drug Conjugates (ADCs) in platinum-sensitive ovarian cancer in the post-PARP era
2天前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
8天前
已完结
Clinical trials in recurrent ovarian cancer
9天前
已完结
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
27天前
已完结
铂敏感复发性卵巢癌诊治中国专家共识(2023年版)
1个月前
已完结
Evaluation of Renal Masses Using Contrast-Enhanced Ultrasound with Sonovue and Sonazoid
3个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
4个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial
4个月前
已完结
Pharmacotherapy for cervical cancer: current standard of care and new perspectives
4个月前
已完结
Immunotherapy for endometrial cancer
5个月前
已完结
皖公网安备34019202002308
